124 related articles for article (PubMed ID: 18060765)
41. The future of imaging techniques for cancer patients in The Netherlands : A Delphi study.
Postma TJ; Alers JC; Terpstra S; Zuurbier A
Eur J Health Econ; 2006 Jun; 7(2):117-22. PubMed ID: 16691374
[TBL] [Abstract][Full Text] [Related]
42. The evolving role of structural and functional imaging in assessment of age-related changes in the body.
Torigian DA; Alavi A
Semin Nucl Med; 2007 Mar; 37(2):64-8. PubMed ID: 17289455
[TBL] [Abstract][Full Text] [Related]
43. Measuring changes in human tumour vasculature in response to therapy using functional imaging techniques.
Anderson H; Price P; Blomley M; Leach MO; Workman P;
Br J Cancer; 2001 Oct; 85(8):1085-93. PubMed ID: 11710817
[TBL] [Abstract][Full Text] [Related]
44. Measures of response: RECIST, WHO, and new alternatives.
Jaffe CC
J Clin Oncol; 2006 Jul; 24(20):3245-51. PubMed ID: 16829648
[TBL] [Abstract][Full Text] [Related]
45. Imaging in clinical trials.
Murphy P; Koh DM
Cancer Imaging; 2010 Oct; 10 Spec no A(1A):S74-82. PubMed ID: 20880784
[TBL] [Abstract][Full Text] [Related]
46. Objective assessment of tumour response to therapy based on tumour growth kinetics.
Mehrara E; Forssell-Aronsson E; Bernhardt P
Br J Cancer; 2011 Aug; 105(5):682-6. PubMed ID: 21792200
[TBL] [Abstract][Full Text] [Related]
47. The use of tumour volumetrics to assess response to therapy in anticancer clinical trials.
Goldmacher GV; Conklin J
Br J Clin Pharmacol; 2012 Jun; 73(6):846-54. PubMed ID: 22242836
[TBL] [Abstract][Full Text] [Related]
48. Predicting tumour response.
Kyle SD; Law WP; Miles KA
Cancer Imaging; 2013 Sep; 13(3):381-90. PubMed ID: 24061161
[TBL] [Abstract][Full Text] [Related]
49. Radiologic investigation of rheumatic diseases.
Babyn P; Doria AS
Rheum Dis Clin North Am; 2007 Aug; 33(3):403-40. PubMed ID: 17936172
[TBL] [Abstract][Full Text] [Related]
50. Monitoring tumour response.
Husband JE
Eur Radiol; 1996; 6(6):775-85. PubMed ID: 8972311
[TBL] [Abstract][Full Text] [Related]
51. Using mathematical models to estimate drug resistance and treatment efficacy via CT scan measurements of tumour volume.
Gregory WM; Reznek RH; Hallett M; Slevin ML
Br J Cancer; 1990 Oct; 62(4):671-5. PubMed ID: 2223589
[TBL] [Abstract][Full Text] [Related]
52. Evolving therapeutic proteins to precisely kill cancer cells.
Zaman R; Islam RA; Chowdhury EH
J Control Release; 2022 Nov; 351():779-804. PubMed ID: 36202153
[TBL] [Abstract][Full Text] [Related]
53. Contrasting the impact of cytotoxic and cytostatic drug therapies on tumour progression.
Anttila JV; Shubin M; Cairns J; Borse F; Guo Q; Mononen T; Vázquez-García I; Pulkkinen O; Mustonen V
PLoS Comput Biol; 2019 Nov; 15(11):e1007493. PubMed ID: 31738747
[TBL] [Abstract][Full Text] [Related]
54. Angiogenesis imaging in neoplasia.
Bowden DJ; Barrett T
J Clin Imaging Sci; 2011; 1():38. PubMed ID: 21977389
[TBL] [Abstract][Full Text] [Related]
55. SYMPOSIUM on anti-tumour agents: cytostatic agents.
Proc R Soc Med; 1957 Jan; 50(1):1-6. PubMed ID: 13400844
[No Abstract] [Full Text] [Related]
56. [In process].
Behncke A; Wolschon E
Pflege Z; 2016 Dec; 69(12):730-2. PubMed ID: 29426112
[No Abstract] [Full Text] [Related]
57. Advanced imaging of colorectal cancer: From anatomy to molecular imaging.
García-Figueiras R; Baleato-González S; Padhani AR; Marhuenda A; Luna A; Alcalá L; Carballo-Castro A; Álvarez-Castro A
Insights Imaging; 2016 Jun; 7(3):285-309. PubMed ID: 27136925
[TBL] [Abstract][Full Text] [Related]
58. Inferring Stable Acquisition Durations for Applications of Perfusion Imaging in Oncology.
Hobbs BP; Ng CS
Cancer Inform; 2015; 14(Suppl 2):193-9. PubMed ID: 26052222
[TBL] [Abstract][Full Text] [Related]
59. Gadofosveset-enhanced MRI as simple surrogate parameter for real-time evaluation of the initial tumour vessel infarction by retargeted tissue factor tTF-NGR.
Höink A; Persigehl T; Kwiecien R; Balthasar M; Mesters R; Berdel W; Heindel W; Bremer C; Schwöppe C
Oncol Lett; 2019 Jan; 17(1):270-280. PubMed ID: 30655764
[TBL] [Abstract][Full Text] [Related]
60. Immuno-Oncology: The Third Paradigm in Early Drug Development.
Martin-Liberal J; Hierro C; Ochoa de Olza M; Rodon J
Target Oncol; 2017 Apr; 12(2):125-138. PubMed ID: 27995439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
